Insights into alternative splicing of sarcomeric genes in the heart

Journal of Molecular and Cellular Cardiology

Volumn 81, Issue , 2015, Pages 107-113

  Weeland, Cornelis J ^a   van den Hoogenhof, Maarten M ^a   Beqqali, Abdelaziz ^a   Creemers, Esther E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Alternative splicing; RBM20; RBM24; Sarcomere; Titin

Indexed keywords

ALPHA TROPOMYOSIN; ANTISENSE OLIGONUCLEOTIDE; CONNECTIN; CONTRACTILE PROTEIN; CYPHER PROTEIN; MYOMESIN; RNA BINDING MOTIF PROTEIN 20; RNA BINDING MOTIF PROTEIN 24; RNA BINDING PROTEIN; TROPOMYOSIN; TROPONIN T; UNCLASSIFIED DRUG; LDB3 PROTEIN, MOUSE; LIM PROTEIN; PROTEIN KINASE; RBM20 PROTEIN, MOUSE; RBM24 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TITIN PROTEIN, MOUSE;

ALTERNATIVE RNA SPLICING; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DRUG EFFECT; DUCHENNE MUSCULAR DYSTROPHY; EXON SKIPPING; GENE MUTATION; HEART DEVELOPMENT; HEART DISEASE; HEART FAILURE; HEART MUSCLE; HEART PROTECTION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SARCOMERE; ANIMAL; CARDIAC MUSCLE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HEART CONTRACTION; METABOLISM; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

MUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALTERNATIVE SPLICING; ANIMALS; CONNECTIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART DISEASES; HUMANS; LIM DOMAIN PROTEINS; MICE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PROTEIN KINASES; RNA-BINDING PROTEINS; SARCOMERES; SIGNAL TRANSDUCTION; TROPOMYOSIN; TROPONIN T;

EID: 84923001691     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.02.008     Document Type: Review

References (81)

1. Wang E.T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
2. Pennisi E. Genomics. ENCODE project writes eulogy for junk DNA. Science 2012, 337:1159-1161.
3. Yu J., Hu S., Wang J., Wong G.K., Li S., Liu B., et al. A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science 2002, 296:79-92.
4. Chen M., Manley J.L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009, 10:741-754.
5. Kong S.W., Hu Y.W., Ho J.W., Ikeda S., Polster S., John R., et al. Heart failure-associated changes in RNA splicing of sarcomere genes. Circ Cardiovasc Genet 2010, 3:138-146.
6. Brauch K.M., Karst M.L., Herron K.J., de Andrade M., Pellikka P.A., Rodeheffer R.J., et al. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol 2009, 54:930-941.
7. Guo W., Schafer S., Greaser M.L., Radke M.H., Liss M., Govindarajan T., et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med 2012, 18:766-773.
8. Kalsotra A., Xiao X., Ward A.J., Castle J.C., Johnson J.M., Burge C.B., et al. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci U S A 2008, 105:20333-20338.
9. Xu X., Yang D., Ding J.H., Wang W., Chu P.H., Dalton N.D., et al. ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 2005, 120:59-72.
10. Lahmers S., Wu Y., Call D.R., Labeit S., Granzier H. Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium. Circ Res 2004, 94:505-513.
11. Opitz C.A., Leake M.C., Makarenko I., Benes V., Linke W.A. Developmentally regulated switching of titin size alters myofibrillar stiffness in the perinatal heart. Circ Res 2004, 94:967-975.
12. Warren C.M., Krzesinski P.R., Campbell K.S., Moss R.L., Greaser M.L. Titin isoform changes in rat myocardium during development. Mech Dev 2004, 121:1301-1312.
13. Ames E.G., Lawson M.J., Mackey A.J., Holmes J.W. Sequencing of mRNA identifies re-expression of fetal splice variants in cardiac hypertrophy. J Mol Cell Cardiol 2013, 62:99-107.
14. Yang J., Hung L.-H., Licht T., Kostin S., Looso M., Khrameeva E., et al. RBM24 is a major regulator of muscle-specific alternative splicing. Dev Cell 2014, 31:87-99.
15. Freiburg A., Trombitas K., Hell W., Cazorla O., Fougerousse F., Centner T., et al. Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. Circ Res 2000, 86:1114-1121.
16. Bang M.L., Centner T., Fornoff F., Geach A.J., Gotthardt M., McNabb M., et al. The complete gene sequence of titin, expression of an unusual 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ Res 2001, 89:1065-1072.
17. Labeit S., Kolmerer B. Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science 1995, 270:293-296.
18. Granzier H.L., Irving T.C. Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments. Biophys J 1995, 68:1027-1044.
19. Helmes M., Trombitas K., Granzier H. Titin develops restoring force in rat cardiac myocytes. Circ Res 1996, 79:619-626.
20. Preetha N., Yiming W., Helmes M., Norio F., Siegfried L., Granzier H. Restoring force development by titin/connectin and assessment of Ig domain unfolding. J Muscle Res Cell Motil 2005, 26:307-317.
21. Trombitas K., Wu Y., Labeit D., Labeit S., Granzier H. Cardiac titin isoforms are coexpressed in the half-sarcomere and extend independently. Am J Physiol Heart Circ Physiol 2001, 281:H1793-H1799.
22. Fukuda N., Wu Y., Farman G., Irving T.C., Granzier H. Titin isoform variance and length dependence of activation in skinned bovine cardiac muscle. J Physiol 2003, 553:147-154.
23. Neagoe C., Kulke M., del Monte F., Gwathmey J.K., de Tombe P.P., Hajjar R.J., et al. Titin isoform switch in ischemic human heart disease. Circulation 2002, 106:1333-1341.
24. Makarenko I., Opitz C.A., Leake M.C., Neagoe C., Kulke M., Gwathmey J.K., et al. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res 2004, 95:708-716.
25. Nagueh S.F., Shah G., Wu Y., Torre-Amione G., King N.M., Lahmers S., et al. Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation 2004, 110:155-162.
26. Methawasin M., Hutchinson K.R., Lee E.J., Smith J.E., Saripalli C., Hidalgo C.G., et al. Experimentally increasing titin compliance in a novel mouse model attenuates the frank-starling mechanism but has a beneficial effect on diastole. Circulation 2014, 129:1924-1936.
27. Li S., Guo W., Dewey C.N., Greaser M.L. Rbm20 regulates titin alternative splicing as a splicing repressor. Nucleic Acids Res 2013, 41:2659-2672.
28. Maatz H., Jens M., Liss M., Schafer S., Heinig M., Kirchner M., et al. RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing. J Clin Invest 2014, 124:3419-3430.
29. Refaat M.M., Lubitz S.A., Makino S., Islam Z., Frangiskakis J.M., Mehdi H., et al. Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy. Heart Rhythm 2012, 9:390-396.
30. Haas J., Frese K.S., Peil B., Kloos W., Keller A., Nietsch R., et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J 2014.
31. LeWinter M.M., Granzier H.L. Titin is a major human disease gene. Circulation 2013, 127:938-944.
32. Fukuda N., Granzier H.L., Ishiwata S., Kurihara S. Physiological functions of the giant elastic protein titin in mammalian striated muscle. J Physiol Sci 2008, 58:151-159.
33. Gray C.B., Heller Brown J. CaMKIIdelta subtypes: localization and function. Front Pharmacol 2014, 5:15.
34. Dzhura I., Wu Y., Colbran R.J., Balser J.R., Anderson M.E. Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels. Nat Cell Biol 2000, 2:173-177.
35. 2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J Biol Chem 2002, 277:1261-1267.
36. Zhang T., Maier L.S., Dalton N.D., Miyamoto S., Ross J., Bers D.M., et al. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 2003, 92:912-919.
37. 2+)/calmodulin-dependent protein kinase II delta (CaMKIIdelta) phosphorylates cardiac titin's spring elements. J Mol Cell Cardiol 2013, 54:90-97.
38. Mishra S., Gray C.B., Miyamoto S., Bers D.M., Brown J.H. Location matters: clarifying the concept of nuclear and cytosolic CaMKII subtypes. Circ Res 2011, 109:1354-1362.
39. Agarkova I., Perriard J.C. The M-band: an elastic web that crosslinks thick filaments in the center of the sarcomere. Trends Cell Biol 2005, 15:477-485.
40. Obermann W.M., Gautel M., Weber K., Furst D.O. Molecular structure of the sarcomeric M band: mapping of titin and myosin binding domains in myomesin and the identification of a potential regulatory phosphorylation site in myomesin. EMBO J 1997, 16:211-220.
41. Agarkova I. A novel marker for vertebrate embryonic heart, the EH-myomesin isoform. J Biol Chem 2000, 275:10256-10264.
42. Schoenauer R., Lange S., Hirschy A., Ehler E., Perriard J.C., Agarkova I. Myomesin 3, a novel structural component of the M-band in striated muscle. J Mol Biol 2008, 376:338-351.
43. Schoenauer R., Bertoncini P., Machaidze G., Aebi U., Perriard J.C., Hegner M., et al. Myomesin is a molecular spring with adaptable elasticity. J Mol Biol 2005, 349:367-379.
44. Siedner S., Kruger M., Schroeter M., Metzler D., Roell W., Fleischmann B.K., et al. Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J Phys 2003, 548:493-505.
45. Agarkova I., Ehler E., Lange S., Schoenauer R., Perriard J.C. M-band: a safeguard for sarcomere stability?. J Muscle Res Cell Motil 2003, 24:191-203.
46. Schoenauer R., Emmert M.Y., Felley A., Ehler E., Brokopp C., Weber B., et al. EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy. Basic Res Cardiol 2011, 106:233-247.
47. Gordon A.M., Homsher E., Regnier M. Regulation of contraction in striated muscle. Physiol Rev 2000, 80:853-924.
48. Anderson P.A., Malouf N.N., Oakeley A.E., Pagani E.D., Allen P.D. Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circ Res 1991, 69:1226-1233.
49. Townsend P.J., Barton P.J., Yacoub M.H., Farza H. Molecular cloning of human cardiac troponin T isoforms: expression in developing and failing heart. J Mol Cell Cardiol 1995, 27:2223-2236.
50. Gomes A.V., Guzman G., Zhao J., Potter J.D. Cardiac troponin T isoforms affect the Ca2+ sensitivity and inhibition of force development. Insights into the role of troponin T isoforms in the heart. J Biol Chem 2002, 277:35341-35349.
51. Anderson P.A., Greig A., Mark T.M., Malouf N.N., Oakeley A.E., Ungerleider R.M., et al. Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ Res 1995, 76:681-686.
52. 2+-sensitivity and arrhythmia susceptibility. J Mol Cell Cardiol 2010, 48:824-833.
53. Ladd A.N., Stenberg M.G., Swanson M.S., Cooper T.A. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev Dyn 2005, 233:783-793.
54. Charlet B.N., Logan P., Singh G., Cooper T.A. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol Cell 2002, 9:649-658.
55. Ho T.H., Charlet B.N., Poulos M.G., Singh G., Swanson M.S., Cooper T.A. Muscleblind proteins regulate alternative splicing. EMBO J 2004, 23:3103-3112.
56. Feng H.Z., Jin J.P. Coexistence of cardiac troponin T variants reduces heart efficiency. Am J Physiol Heart Circ Physiol 2010, 299:H97-H105.
57. Wei B., Jin J.P. Troponin T isoforms and posttranscriptional modifications: evolution, regulation and function. Arch Biochem Biophys 2011, 505:144-154.
58. Denz C.R., Narshi A., Zajdel R.W., Dube D.K. Expression of a novel cardiac-specific tropomyosin isoform in humans. Biochem Biophys Res Commun 2004, 320:1291-1297.
59. Rajan S., Jagatheesan G., Karam C.N., Alves M.L., Bodi I., Schwartz A., et al. Molecular and functional characterization of a novel cardiac-specific human tropomyosin isoform. Circulation 2010, 121:410-418.
60. Huang C., Zhou Q., Liang P., Hollander M.S., Sheikh F., Li X., et al. Characterization and in vivo functional analysis of splice variants of cypher. J Biol Chem 2003, 278:7360-7365.
61. Zhou Q., Chu P.H., Huang C., Cheng C.F., Martone M.E., Knoll G., et al. Ablation of cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J Cell Biol 2001, 155:605-612.
62. Cheng H., Zheng M., Peter A.K., Kimura K., Li X., Ouyang K., et al. Selective deletion of long but not short cypher isoforms leads to late-onset dilated cardiomyopathy. Hum Mol Genet 2011, 20:1751-1762.
63. Zheng M., Cheng H., Li X., Zhang J., Cui L., Ouyang K., et al. Cardiac-specific ablation of cypher leads to a severe form of dilated cardiomyopathy with premature death. Hum Mol Genet 2009, 18:701-713.
64. Zhou Q., Ruiz-Lozano P., Martone M.E., Chen J. Cypher, a striated muscle-restricted PDZ and LIM domain-containing protein, binds to alpha-actinin-2 and protein kinase C. J Biol Chem 1999, 274:19807-19813.
65. Arimura T., Inagaki N., Hayashi T., Shichi D., Sato A., Hinohara K., et al. Impaired binding of ZASP/cypher with phosphoglucomutase 1 is associated with dilated cardiomyopathy. Cardiovasc Res 2009, 83:80-88.
66. Poon K.L., Tan K.T., Wei Y.Y., Ng C.P., Colman A., Korzh V., et al. RNA-binding protein RBM24 is required for sarcomere assembly and heart contractility. Cardiovasc Res 2012, 94:418-427.
67. Park C.Y., Pierce S.A., von Drehle M., Ivey K.N., Morgan J.A., Blau H.M., et al. skNAC, a Smyd1-interacting transcription factor, is involved in cardiac development and skeletal muscle growth and regeneration. Proc Natl Acad Sci U S A 2010, 107:20750-20755.
68. Mientjes E.J., Willemsen R., Kirkpatrick L.L., Nieuwenhuizen I.M., Hoogeveen-Westerveld M., Verweij M., et al. Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo. Hum Mol Genet 2004, 13:1291-1302.
69. Whitman S.A., Cover C., Yu L., Nelson D.L., Zarnescu D.C., Gregorio C.C. Desmoplakin and talin2 are novel mRNA targets of fragile X-related protein-1 in cardiac muscle. Circ Res 2011, 109:262-271.
70. van Bon B.W., Gilissen C., Grange D.K., Hennekam R.C., Kayserili H., Engels H., et al. Cantu syndrome is caused by mutations in ABCC9. Am J Hum Genet 2012, 90:1094-1101.
71. Bosch-Comas A., Lindsten K., Gonzalez-Duarte R., Masucci M.G., Marfany G. The ubiquitin-specific protease USP25 interacts with three sarcomeric proteins. Cell Mol Life Sci 2006, 63:723-734.
72. Valero R., Bayes M., Francisca Sanchez-Font M., Gonzalez-Angulo O., Gonzalez-Duarte R., Marfany G. Characterization of alternatively spliced products and tissue-specific isoforms of USP28 and USP25. Genome Biol 2001, 2. RESEARCH0043.
73. Jiang Y., Zhang M., Qian Y., Xu E., Zhang J., Chen X. Rbm24, an RNA-binding protein and a target of p53, regulates p21 expression via mRNA stability. J Biol Chem 2014, 289:3164-3175.
74. Konig J., Zarnack K., Luscombe N.M., Ule J. Protein-RNA interactions: new genomic technologies and perspectives. Nat Rev Gen 2011, 13:77-83.
75. Castello A., Fischer B., Eichelbaum K., Horos R., Beckmann B.M., Strein C., et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 2012, 149:1393-1406.
76. Goemans N.M., Tulinius M., van den Akker J.T., Burm B.E., Ekhart P.F., Heuvelmans N., et al. Systemic administration of PRO051 in Duchenne's muscular dystrophy. N Engl J Med 2011, 364:1513-1522.
77. Scaffidi P., Misteli T. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med 2005, 11:440-445.
78. Hua Y., Sahashi K., Rigo F., Hung G., Horev G., Bennett C.F., et al. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 2011, 478:123-126.
79. Wheeler T.M., Leger A.J., Pandey S.K., MacLeod A.R., Nakamori M., Cheng S.H., et al. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 2012, 488:111-115.
80. Felkin L.E., Narita T., Germack R., Shintani Y., Takahashi K., Sarathchandra P., et al. Calcineurin splicing variant calcineurin Abeta1 improves cardiac function after myocardial infarction without inducing hypertrophy. Circulation 2011, 123:2838-2847.
81. Santini M.P., Lexow J., Borsellino G., Slonimski E., Zarrinpashneh E., Poggioli T., et al. IGF-1Ea induces vessel formation after injury and mediates bone marrow and heart cross-talk through the expression of specific cytokines. Biochem Biophys Res Commun 2011, 410:201-207.